 The purpose of this study is to integrate the post-marketing surveillances data Specified use-results surveys on long-term treatment of the 6 SGLT2 inhibitors approved or applied in Japan and to evaluate the safety and efficacy of long-term use of each under actual clinical practice conditions. 